Sab Biotherapeutics Inc. (SABS)

Market Closed

16 Oct, 08:00 PM

NASDAQ (CM)

$

2. 53

-0.06

-2.3166%

271.14M Market Cap

0.1 P/E Ratio

- Div Yield

756,767 Volume

0 Eps

$ 2.59

Previous Close

Investors:

Add Transaction

Day Range

2.47 2.63

Year Range

2.1 5.15

Want to track SABS and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

Sab Biotherapeutics Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
JD Jim Dushek HARBOUR INVESTMENTS Inc.	50	$227	$124.5	-$102.5	-45.15%
CD Charlie Durham Sterling Capital Management LLC	875	$3,413	$2,178.75	-$1,234.25	-36.16%
Joseph Castro Nuveen LLC	58,398	$227,752	$145,411.02	-$82,340.98	-36.15%
W. Travis McKinney HB Wealth Management LLC	307,500	$618,075	$796,425	$178,350	28.86%
Kevin Roan Stempoint Capita LLP	342,631	$1.3M	$873,709.05	-$428,290.73	-32.89%
Hui Fai Tam Caitong International Asset Management Co. Ltd.	742	$2,883.06	$1,921.78	-$961.28	-33.34%
Jim Harding Propel Bio Management LLC	1.08M	$4.07M	$2.75M	-$1.32M	-32.44%
Angus Yuk Chi Wai Polymer Capital Management (HK) Ltd.	306,581	$1.2M	$775,649.93	-$420,016.06	-35.13%
Christopher C. Powers Farther Finance Advisors, LLC	21	$67	$52.29	-$14.71	-21.96%
RJ Rebecca Judd Pathstone Holdings, LLC	50,650	$229,953	$131,183.5	-$98,769.5	-42.95%
MA Marie-Andree Alain Federation des caisses Desjardins du Quebec	2,000	$7,800	$5,180	-$2,620	-33.59%
Mark Schafer Police & Firemen's Retirement System of New Jersey	12,807	$49,947	$31,889.43	-$18,057.57	-36.15%
Yuen Man Lee Persistent Asset Partners Ltd.	25,400	$97,282.16	$63,754	-$33,528.16	-34.46%

1

Blog Affiliate Program Dividend Tracker About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.